Hyperactivity induced by the dopamine D2/D3 receptor agonist quinpirole is attenuated by inhibitors of endocannabinoid degradation in mice

The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats

(2012) Przemysław Adamczyk et al.   BRAIN RESEARCH

Brain cannabinoid CB2 receptors modulate cocaine's actions in mice

(2011) Zheng-Xiong Xi et al.   NATURE NEUROSCIENCE

Attenuation of cocaine-induced conditioned locomotion is associated with altered expression of hippocampal glutamate receptors in mice lacking LPA1 receptors

(2011) Eduardo Blanco et al.   PSYCHOPHARMACOLOGY

Cocaine modulates both glutaminase gene expression and glutaminase activity in the brain of cocaine-sensitized mice

(2011) Eduardo Blanco et al.   PSYCHOPHARMACOLOGY

Differential DAergic Control of D1 and D2 Receptor Agonist Over Locomotor Activity and GABA Level in the Striatum

(2011) Eun-Yee Jung et al.   Experimental Neurobiology

Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-α nuclear receptors

(2010) Antonio Luchicchi et al.   ADDICTION BIOLOGY

Modulation of anxiety by acute blockade and genetic deletion of the CB1 cannabinoid receptor in mice together with biogenic amine changes in the forebrain

(2009) Gunnar Thiemann et al.   BEHAVIOURAL BRAIN RESEARCH

Methanandamide attenuates cocaine-induced hyperthermia in rats by a cannabinoid CB1-dopamine D2 receptor mechanism

(2009) Bruce A. Rasmussen et al.   BRAIN RESEARCH

Role of the endocannabinoid system in metabolic control

(2009) Jun Wang et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice

(2009) Leonora E. Long et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A Role for the Endocannabinoid System in the Increased Motivation for Cocaine in Extended-Access Conditions

(2009) L. Orio et al.   JOURNAL OF NEUROSCIENCE

Role of cannabis and endocannabinoids in the genesis of schizophrenia

(2009) Emilio Fernandez-Espejo et al.   PSYCHOPHARMACOLOGY

The Endocannabinoid System: A New Molecular Target for the Treatment of Tobacco Addiction

(2008) Maria Scherma et al.   CNS & Neurological Disorders-Drug Targets

Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity

(2008) Louise Adermark et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

D2receptor-mediated inhibition of dopamine release in the rat striatumin vitrois modulated by CB1receptors: studies using fast cyclic voltammetry

(2008) Carmel O’Neill et al.   JOURNAL OF NEUROCHEMISTRY

Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown

(2008) Ekaterina A. Placzek et al.   NEUROPHARMACOLOGY

Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum

(2008) Matthijs G Bossong et al.   NEUROPSYCHOPHARMACOLOGY

Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout mice

(2008) Xia Li et al.   PSYCHOPHARMACOLOGY

Detection of Heteromers Formed by Cannabinoid CB1, Dopamine D2, and Adenosine A2AG-Protein-Coupled Receptors by Combining Bimolecular Fluorescence Complementation and Bioluminescence Energy Transfer

(2008) Gemma Navarro et al.   TheScientificWorldJOURNAL